Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MAGE‐C1/CT‐7 expression in plasma cell myeloma: Sub‐cellular localization impacts on clinical outcome

27 Feb 2008

Abstract excerpt

Plasma cell myelomas (PMs) have a poor prognosis. Cancer-testis (CT) antigens are immunogenic proteins, representing potential targets for tumor vaccination strategies. The expression of the CT antigens GAGE, MAGE-A4, MAGE-C1/CT-7, and NY-ESO-1 was investigated on paraffin-embedded bone marrow biopsies from 219 PM and 8 monoclonal gammopathy of undetermined significance (MGUS) patients. The frequency and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Multiple Myeloma Research and Treatments
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18307538
DOI: 10.1111/j.1349-7006.2008.00738.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MAGE‐C1/CT‐7 expression in plasma cell myeloma: Sub‐cellular localization impacts on clinical outcomePMID 18307538Read ↗

Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple MyelomaSemantic proximity Read ↗

The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma.Semantic proximity Read ↗

Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.Semantic proximity Read ↗

Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.Semantic proximity Read ↗

CD8+T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burdenSemantic proximity Read ↗

Sperm protein 17 is a novel cancer-testis antigen in multiple myelomaSemantic proximity Read ↗

The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patientsSemantic proximity Read ↗

NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimensSemantic proximity Read ↗

Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patientsSemantic proximity Read ↗

Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.Semantic proximity Read ↗

Fine analysis of spontaneous MAGE-C1/CT7–specific immunity in melanoma patientsSemantic proximity Read ↗

Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.